The Impact of Mesenchymal Stem Cells on the Treatment of Long-Term Non-Healing Wounds

Chronic wounds pose a significant healthcare burden due to their prolonged healing time, susceptibility to infection, and associated morbidity.Conventional treatment modalities often fail to achieve satisfactory outcomes in these cases, necessitating the exploration of alternative therapeutic approaches.Mesenchymal stem cells (MSCs) have emerged as a promising strategy for the management of long-term non-healing wounds, owing to their unique immunomodulatory, anti-inflammatory, and regenerative properties.This comprehensive review examines the impact of MSC therapy on the treatment of chronic wounds, drawing upon preclinical and clinical studies to elucidate the underlying mechanisms of action and therapeutic efficacy.We discuss the ability of897MSCs to modulate the inflammatory response, promote angiogenesis, enhance extracellular matrix remodeling, and stimulate tissue regeneration, all of which are critical processes in wound healing.Additionally, we explore the safety profile of MSC therapy and its potential for improving wound closure rates, reducing woundrelated complications, and enhancing overall patient outcomes.Despite the promising results reported in the literature, several challenges and limitations remain, including variability in study design, cell source heterogeneity, and the need for standardized protocols.Future research directions are also discussed, including the optimization of MSC delivery methods, identification of optimal patient selection criteria, and exploration of combination therapies to augment the therapeutic effects of MSCs.Overall, this review highlights the considerable potential of MSC therapy as a novel and effective approach for the treatment of longterm non-healing wounds, while also underscoring the importance of continued research efforts to further elucidate its clinical utility and optimize treatment strategies.